Vivoryon Therapeutics NV
AEX:VVY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Vivoryon Therapeutics NV
Selling, General & Administrative
Vivoryon Therapeutics NV
Selling, General & Administrative Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Vivoryon Therapeutics NV
AEX:VVY
|
Selling, General & Administrative
-€6.8m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-7%
|
|
|
BioNTech SE
NASDAQ:BNTX
|
Selling, General & Administrative
-€617.5m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
N/A
|
|
|
CureVac NV
NASDAQ:CVAC
|
Selling, General & Administrative
-€66.3m
|
CAGR 3-Years
11%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
Immatics NV
NASDAQ:IMTX
|
Selling, General & Administrative
-€49m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
Immunic Inc
NASDAQ:IMUX
|
Selling, General & Administrative
-$21.2m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-6%
|
|
|
Biotest AG
XETRA:BIO
|
Selling, General & Administrative
-€85.6m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
2%
|
|
Vivoryon Therapeutics NV
Glance View
The company is headquartered in Halle, Sachsen-Anhalt and currently employs 16 full-time employees. The company went IPO on 2014-10-27.
See Also
What is Vivoryon Therapeutics NV's Selling, General & Administrative?
Selling, General & Administrative
-6.8m
EUR
Based on the financial report for Dec 31, 2024, Vivoryon Therapeutics NV's Selling, General & Administrative amounts to -6.8m EUR.
What is Vivoryon Therapeutics NV's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-7%
Over the last year, the Selling, General & Administrative growth was 20%. The average annual Selling, General & Administrative growth rates for Vivoryon Therapeutics NV have been -14% over the past three years , -18% over the past five years , and -7% over the past ten years .
